Симбикорт

Симбикорт combines budesonide and formoterol fumarate for inhalation use, offering dual-action relief for respiratory conditions. This EU-manufactured medication supports long-term asthma and COPD management with consistent symptom control. Ideal for daily maintenance therapy in adults and children. Seek medical advice for personalized dosing.

Симбикорт is used to control and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). It combines a corticosteroid (budesonide) to reduce inflammation and a long-acting bronchodilator (formoterol) to open airways. This combination helps manage persistent breathing difficulties and reduces flare-ups over time. It is not intended for sudden asthma attacks.

After inhalation, Симбикорт begins working within minutes to relax airway muscles, easing breathing. Regular use may lead to improved lung function and fewer respiratory symptoms over weeks. Some users report reduced wheezing and coughing. Effects vary by individual and consistent use is important for best results.

Keep Симбикорт away from extreme temperatures and moisture. Store the inhaler upright in a cool, dry place. Avoid exposing the device to direct sunlight or freezing conditions. Always check the mouthpiece for debris before use. If the inhaler is dropped or damaged, consult a healthcare provider before continuing.

Симбикорт may interact with certain medications, including strong CYP3A4 inhibitors like ketoconazole or ritonavir, which can increase steroid levels. Beta-blockers, such as propranolol, may reduce the effectiveness of formoterol. Diuretics and other steroids can affect potassium levels. Always inform your doctor about all medications you are taking.